Back to search

Article

A novel 20-gene prognostic score in pancreatic adenocarcinoma

2019-09-30

Abstract excerpt

<title>Abstract</title> <p>Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers. Known risk factors for this disease are currently insufficient in predicting mortality. The only FDA approved prognostic biomarker for PDAC patients is CA19-9. This, along with AJCC TNM staging and performance status, are considered important prognostic indicators in clinical practice. In order to better prognosti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
222a827b-6bbd-54b3-9e8b-d6db9c3cdfaf
DOI
10.21203/rs.2.15410/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A novel 20-gene prognostic score in pancreatic adenocarcinomaDOI 10.21203/rs.2.15410/v1
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinomaSemantic proximity
Molecular classification and prognosis study of pancreatic ductal adenocarcinoma through multi-omics integrated clustering analysis.Semantic proximity
Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancerSemantic proximity
Single-cell transcriptomics analysis reveals dynamic changes and prognostic signature in tumor microenvironment of PDACSemantic proximity
A transcriptomics-based meta-analysis combined with machine learning approach identifies a secretory biomarker panel for diagnosis of pancreatic adenocarcinomaSemantic proximity
Identification of a novel immune-related gene prognostic index in pancreatic adenocarcinoma and its implication on tumor immunologySemantic proximity
In Silico RNA-Seq Analysis Reveals Key Transcriptomic Signatures in Pancreatic CancerSemantic proximity
Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal AdenocarcinomaSemantic proximity
Meta-analysis of 1,200 transcriptomic profiles identifies a prognostic model for pancreatic ductal adenocarcinomaSemantic proximity
Comprehensive Genomic Analysis of the Prognostic and Immunological Characteristics of Tertiary Lymphoid structures and CD8+ T-cells in Pancreatic Ductal AdenocarcinomaSemantic proximity
A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal AdenocarcinomaSemantic proximity
Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal AdenocarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.